In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vicuron Pharmaceuticals Inc.

Division of Allergan PLC
www.vicuron.com

Latest From Vicuron Pharmaceuticals Inc.

Durata Plans To Pitch Dalbavancin As Cost-Saving Paradigm Changer

Company plans to file an NDA for the antibiotic in September, built partly on clinical work done by the drug’s previous owner, Pfizer. Given hospitals’ emphasis on cost, Durata’s marketing plan will highlight the drug’s two-dose regimen, which could help move treatment to the ambulatory-care setting.

BioPharmaceutical United States

Soon To Start Antibiotic Trial In China, MicuRx Gets $25M For U.S. Testing

Chinese-U.S. hybrid MicuRx, founded by Vicuron veterans, has strong preclinical and Phase I data for a novel antibiotic targeting Gram-positive infections. Its cross-border approach will soon support two mid-stage trials.

BioPharmaceutical China

Soon To Start Antibiotic Trial In China, MicuRx Gets $25M For U.S. Testing

A six-year-old start-up founded by Vicuron veterans has strong preclinical and Phase I data for a novel antibiotic targeting Gram-positive infections. Its cross-border approach will soon support two mid-stage trials.

BioPharmaceutical China

Durata Sets Sights On Commercialization As Dalbavancin Nears Filing

After completing an initial public offering in July, announcing plans to relocate its corporate headquarters to Chicago in November and releasing positive Phase III data on its lead drug, the antibiotic dalbavancin, Dec. 11, Durata Therapeutics is laying the groundwork to transition to a commercial drug company.

BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Versicor Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Dov A Goldstein, MD, EVP, CFO
    Lyn Wiesinger, SVP, Mktg. & Market Dev.
    Albert Collinson, VP, Bus. Dev.
    Richard White, PhD, EVP, CSO
  • Contact Info
  • Vicuron Pharmaceuticals Inc.
    Phone: (610) 205-2300
    455 South Gulph Rd.
    Ste. 305
    King of Prussia, PA 19406
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register